Which drugs are up, which are down?

Update: 2024-08-20

Description

In the show's second episode, host Vanda Felbab-Brown talks with Dr. Peter Reuter and Dr. Greg Midgette, criminology professors at the University of Maryland, about the current state of the U.S. drug market, discussing changes to U.S. consumption patterns from cocaine to various opioids. The episode also explores the dramatic rise in lethality in the U.S. drug market, not just because of the widespread prevalence of fentanyl, but also because of the increasing potency of methamphetamine.

Show notes and transcript.

Brought to you by the Brookings Podcast Network.

Learn more at: Brookings.edu/KillingDrugs

Comments

In Channel

Youth, fentanyl, and the urgency of honest conversations

2024-10-3034:54

From cradle to grave: Responding to Nevada's fentanyl crisis

2024-10-2931:57

The emerging fentanyl risk in South America

2024-10-2233:58

The rising threat of synthetic opioids in Europe

2024-10-1534:56

US-Mexico relations and the fight against fentanyl trafficking

2024-10-0838:13

The fentanyl pipeline and China's role in the US opioid crisis

2024-10-0134:11

Fentanyl's impact on Native American communities and paths to recovery

2024-09-2435:05

The rise and fall of drug decriminalization in the Pacific Northwest

2024-09-1738:07

Rethinking domestic law enforcement in the fentanyl crisis

2024-09-1039:08